Membership

A: To be eligible for TransCelerate membership, your company must: 

• Be a pharmaceutical or biotechnical company engaged in the business of innovative discovery, research, development, and manufacturing of new drugs or new therapeutic biological products.
  • This includes developers and makers of vaccines.
  • This does not include companies who only develop and manufacture medical devices and / or diagnostics.
• Companies must manufacture the drugs or therapeutic biological products or contract with a third-party manufacturer, either to be sold in commercial markets or used in clinical trials.
• Have annual R&D spend information available to share, as this determines member fees.
• Not have filed for bankruptcy within the last three years. 

A: While TransCelerate membership is limited to pharmaceutical / biopharmaceutical companies, there are a variety of ways we engage with other industry stakeholder groups, such as CROs through the ACRO Forum.

A: Yes! There are several ways that you can stay involved with TransCelerate as a non-member:

• Sign up for our Awareness & Implementation Community to receive information about new solutions that could help you and your company, free educational webinars hosted by solution experts from our membership, impactful solution testimonials to inform your business case for implementation, and new tools to assist you on your awareness & implementation journey.
• Follow TransCelerate on LinkedIn and YouTube to receive updates about our solutions and events and to interact with the TransCelerate community.
• Learn more about TransCelerate through recent blogs, solution releases, and events.

A: Please complete a member exploration form here. A TransCelerate team member will be in contact with you once we have assessed your submission. If your company meets the eligibility requirements, we will schedule an introductory phone call to discuss membership, topics of interest, and next steps. A full overview of the application process can be found here.

A: There are two components to TransCelerate membership – a monetary component (dues) and an FTE commitment. TransCelerate has three membership tiers, based on a member’s global R&D budget. Those tiers inform dues and FTE commitment for each member. Annual dues are determined and approved by the board of directors. The FTE commitment is central to the TransCelerate mission, as the contribution of member company talent enables delivery of our portfolio.

A: TransCelerate’s Comparator Network establishes a reliable, rapid platform for Network members to buy comparator drugs from other companies participating in the Network. Sourcing quality comparator drug products for use in clinical trials from participating member companies avoids counterfeiting and delays in study start-up. More information about the Comparator Network can be found here. 

To join the Comparator Network, your company must be a TransCelerate member, meet certain eligibility criteria, be approved by current members, and sign the network agreement. Part of the eligibility criteria includes commitment to reciprocal information exchange (i.e., members are expected to contribute information).

Note: TransCelerate members are expected to contribute to initiatives beyond the Comparator Network, even if the Comparator Network is a member’s primary initiative of interest.

A: To join a TransCelerate data sharing project, your company must be a TransCelerate member, sign the relevant data sharing agreement (and meet its conditions), data processing agreement, and the second-tier user agreement.   

Note: TransCelerate members are expected to contribute to initiatives beyond clinical data sharing, even if clinical data sharing is a member’s primary initiative of interest.

A: DataCelerate® is a global technology platform for clinical trials that allows for multiple de-identified research and development data types to be voluntarily submitted, uploaded, converted, harmonized, and downloaded through an access-controlled, secured environment. Serving as a data lake solution, the robust development and scalable design of DataCelerate® features a flexible single sign-on platform with an automated user interface to quickly develop translational insights across the R&D continuum. DataCelerate® is used to host TransCelerate and BioCelerate’s data sharing projects.  More information about DataCelerate® can be found here.

A: You can learn more about specific initiatives here. If you have additional questions about an initiative, please contact us at info@transceleratebiopharmainc.com and we will direct your request to the appropriate expert.